ArticleMedicine2022

Methylation of PCDH17 and NEFH as prognostic biomarker for nonmetastatic RCC: A cohort study.

Antonios Koudonas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.